Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$51.99
+0 (+0%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

EN DIRECT DES MARCHES : Total, Vinci, Airbus, ADP, Seb, Neovacs, Compass, ThyssenKrupp, JC Penney...

 12:50pm, Monday, 18'th May 2020

ChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)

 12:30pm, Monday, 18'th May 2020
ChemoCentryx, Inc., (CCXI) and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced topline data from a forty-six (46) patient Phase II dose-ranging trial in the orphan kidney disorder,

Eloge de l'ignorance

 07:06am, Monday, 18'th May 2020

Vifor: échec d'une collaboration clinique contre la glomérulosclérose | Zone bourse

 05:22am, Monday, 18'th May 2020

ChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)

 12:00am, Monday, 18'th May 2020

Analysts Have Just Cut Their ChemoCentryx, Inc. (NASDAQ:CCXI) Revenue Estimates By 11%

 02:49pm, Saturday, 16'th May 2020
Market forces rained on the parade of ChemoCentryx, Inc. (NASDAQ:CCXI) shareholders today, when the analysts...

Integral Health Asset Management, LLC Buys Merck Inc, AstraZeneca PLC, Catalent Inc, Sells ...

 12:00am, Friday, 15'th May 2020

ChemoCentryx, Inc. (NASDAQ:CCXI) Just Reported And Analysts Have Been Cutting Their Estimates

 10:53am, Thursday, 14'th May 2020
It's shaping up to be a tough period for ChemoCentryx, Inc. (NASDAQ:CCXI), which a week ago released some...

JP Morgan Maintains Overweight on ChemoCentryx, Raises Price Target to $64

 12:00am, Thursday, 14'th May 2020

ChemoCentryx, Inc. (CCXI) CEO Dr. Thomas Schall on Q1 2020 Results - Earnings Call Transcript

 07:35pm, Wednesday, 13'th May 2020
ChemoCentryx, Inc. (NASDAQ:CCXI) Q1 2020 Results Conference Call May 11, 2020 05:00 PM ET Company Participants Bill Slattery - IR, Burns McClellan Dr. Thomas Sc

Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C. and Los Angeles County.

 04:49pm, Wednesday, 13'th May 2020

The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter

 12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Acceleron Pharma Inc (NASDAQ...

ChemoCentryx Inc (CCXI) Q1 2020 Earnings Call Transcript

 05:30pm, Tuesday, 12'th May 2020
Joining me on the call today is Dr. Thomas Schall, President and Chief Executive Officer of ChemoCentryx, who will review the company's recent business and clinical progress. Following his comments,

Stocks That Hit 52-Week Highs On Tuesday

 02:41pm, Tuesday, 12'th May 2020

Biotech's Golden Moment As Healthcare Attracts Investors

 01:31pm, Tuesday, 12'th May 2020
Biotechs are not as broadly and deeply affected by COVID-19 disruption and now lead the market as the economy begins the recovery process. Healthcare has attrac
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE